Respondents also expressed their uncertainty about what the new guidelines recommend for specific patients, with the result indicating that most GPs prescribe fewer DPP-4ins, SGLT2ins, and GLP-1 RAs to older individuals with diabetes compared with to younger individuals (although the indications for these medications are more common in the elderly) (Supplementary Table S3). Here, GLP1R is linked to diabetes mellitus.